Germano, I M <br/><br/>
Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.  [electronic resource] 

 -  Cancer gene therapy  Sep 2010 
 - 664-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-5500 
<br/><br/><label>Standard No.: </label>10.1038/cgt.2010.31  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Apoptosis<br/>Blotting, Western<br/>Brain Neoplasms--drug therapy<br/>Cell Proliferation<br/>Cells, Cultured<br/>Combined Modality Therapy<br/>Dacarbazine--analogs & derivatives<br/>Drug Delivery Systems<br/>Drug Resistance, Neoplasm--genetics<br/>Embryonic Stem Cells--physiology<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Gene Transfer Techniques<br/>Genetic Therapy<br/>Genetic Vectors--therapeutic use<br/>Glioma--drug therapy<br/>Humans<br/>Immunoenzyme Techniques<br/>Interleukins--genetics<br/>Mice<br/>Mice, Nude<br/>RNA, Messenger--genetics<br/>Radiation, Ionizing<br/>Radiation-Sensitizing Agents<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Temozolomide<br/>Transgenes--physiology<br/>Tumor Stem Cell Assay